Skip to main content

Want a detailed portfolio tracker?

Harmony Biosciences (HRMY) P/E (2020 - 2026)

Harmony Biosciences (HRMY) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Harmony Biosciences (HRMY) P/E is 14.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Harmony Biosciences (HRMY)

YearP/EChange
202614.59+7.51%
202513.57+0.66%
202413.48+5.74%
202312.75-39.13%
202220.94-70.58%
202171.19-94.12%
20201.21KN/A

Comparison Harmony Biosciences (HRMY) P/E with competitors

Harmony Biosciences (HRMY) P/E is 14.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.97%
ENLVEnlivex Ltd0.07-99.49%
FGENFibroGen Inc0.24-98.35%
CHRSCoherus Biosciences Inc0.85-94.18%
FBIOFortress Biotech Inc0.95-93.49%
ORMPOramed Pharmaceuticals Inc1.50-89.70%
AGENAgenus Inc3.01-79.37%
INVAInnoviva Inc3.15-78.38%
VXRTVaxart Inc3.55-75.67%
CRMDCorMedix Inc3.63-75.13%
CVACCureVac N.V.4.45-69.52%
GLPGGalapagos NV4.86-66.69%
SRPTSarepta Therapeutics Inc4.88-66.53%
ABEOAbeona Therapeutics Inc5.39-63.07%
ABUSArbutus Biopharma Corp5.60-61.64%
ZVRAZevra Therapeutics Inc5.89-59.64%
SPROSpero Therapeutics Inc6.23-57.30%
CGENCompugen Ltd6.31-56.72%
RIGLRigel Pharmaceuticals6.87-52.89%
SLXNSilexion Therapeutics Corp7.30-49.98%
OMEROmeros Corporation9.26-36.53%
AUPHAurinia Pharmaceuticals Inc9.58-34.29%
PLXProtalix BioTherapeutics Inc10.89-25.34%
ACADAcadia Pharmaceuticals Inc11.73-19.60%
TBPHTheravance Biopharma Inc12.26-15.94%
ADMAAdma Biologics Inc12.42-14.87%
SABSSAB Biotherapeutics Inc14.14-3.09%
NAGENiagen Bioscience Inc14.82+1.59%
INCYIncyte Corp15.82+8.47%
REGNRegeneron Pharmaceuticals Inc15.86+8.70%
PBYIPuma Biotechnology Inc17.32+18.71%
CPRXCatalyst Pharmaceuticals Inc17.44+19.55%
EXELExelixis Inc17.54+20.23%
TGTXTG Therapeutics Inc18.97+30.02%
MDXGMimedx Group Inc20.55+40.90%
XOMAXOMA Royalty Corp22.87+56.82%
ARGXArgen X SE24.30+66.58%
CTMXCytomX Therapeutics Inc24.82+70.16%
XOMAOXOMA Royalty Corp25.34+73.76%
HALOHalozyme Therapeutics Inc25.62+75.67%
XOMAPXOMA Royalty Corp25.67+75.99%
VRTXVertex Pharmaceuticals Inc27.99+91.92%
RPRXRoyalty Pharma plc - Class A28.69+96.67%
SLNOSoleno Therapeutics Inc29.02+98.92%
ASNDAscendis Pharma A/S30.09+106.26%
LGNDLigand Pharmaceuticals Inc - Class B37.91+159.91%
APLSApellis Pharmaceuticals Inc39.02+167.52%
BMRNBiomarin Pharmaceutical Inc42.21+189.39%
KRYSKrystal Biotech Inc45.34+210.86%
ONCBeiGene Ltd69.54+376.74%
PHARPharming Group N.V.75.03+414.35%
TECHBio-Techne Corp101.96+598.99%
VCELVericel Corp109.92+653.58%
ALNYAlnylam Pharmaceuticals Inc117.96+708.73%
GMABGenmab140.29+861.78%
TLXTelix Pharmaceuticals Ltd162.15+1011.66%
CORTCorcept Therapeutics Inc212.86+1359.28%